Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Arrowhead Pharmaceuticals, Inc.

NASDAQ: ARWRHealthcare / Biotechnology / USA
14.52-0.1100-0.75%Vol 1 495 3081Y Perf 152.80%
Jan 18th, 2019 16:00
BID14.52 ASK14.53
Open14.62 Previous Close14.63
Pre-Market- After-Trading14.10
 - -%  -0.42 -2.89%
Target Price
24.42 
Analyst Rating
Strong Buy 1.00
Potencial %
68.18 
Finscreener Ranking
★★★★     54.25
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★+     43.55
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★+     54.56
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)1 339 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
55.33 
Earnings Date
8th Feb 2019

Today's Price Range

14.1014.96

 

52wk Range

4.7722.39

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
7.96%
3 Months
11.26%
6 Months
-10.97%
1 Year
152.80%
3 Years
278.13%
5 Years
17.95%

Quotes

Name / TickerPriceChg.Chg.%
ARWR14.52-0.1100-0.75
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
6.20
Current Ratio
6.40
Long Term Debt to Total Capital
0.02
Total Debt to Equity
0.02
Interest Coverage
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-346.50
EBITDA Margin
-317.40
Pre-tax Profit Margin
-21 936.40
Profit Margin
-78.74
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
14.32
PS Ratios
108.56
Price to Cash Flow
-
Price to Free Cash Flow
-40.60
Cash Flow Per Share
-0.53
Price to Tangible Book
17.80
Book Value per Share
1.04
Enterprise Value (in ths.)
1 297 170
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-62.31
ROE last 12 Months
-61.45
Return on Assets (5Y Avg)
-59.57
ROA last 12 Months
-50.50
Return on Capital (5Y Avg)
-60.64
ROC last 12 Months
-40.38
Return on invested Capital Q
-10.61
Return on invested Capital Y
-60.96
Assets Turnover
0.00
Receivables Turnover
12.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
12 633
Revenue per Share
0.14
Revenue Growth 3 Years
489.08
Revenue Growth 5 Years
190.39
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q04 2018-0.17-0.1229.41
Q03 2018-0.19-0.185.26
Q02 2018-0.18-0.180.00
Q01 2018-0.18-0.180.00
Q04 2017-0.12-0.14-16.67
Q03 2017-0.13-0.0746.15
Q02 2017-0.12-0.0833.33
Q01 2017-0.18-0.175.56
Earnings Per EndEstimateRevision %Trend
12/2018 QR0.76575.00Positive
3/2019 QR0.30314.29Positive
9/2019 FY1.49366.07Positive
9/2020 FY-0.24-200.00Negative
Next Report Date8th Feb 2019
Estimated EPS Next Report0.76
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume1 495 308
Shares Outstanding (in ths.)92 225
Trades Count6 985
Dollar Volume19 316 355
Avg. Volume1 690 516
Avg. Weekly Volume1 148 101
Avg. Monthly Volume1 867 445
Avg. Quarterly Volume1 729 984

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

62%38%

Bearish Bullish

43%57%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
5 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News